Answers are grounded in this paper and cite their sources.
Background High myopia in children and adolescents is a growing public health concern associated with increased risk of irreversible vision impairment. Identifying the most effective and safe intervention to slow its progression is critical. Methods We searched PubMed, EMBASE, Scopus, Cochrane Library, ClinicalTrials.gov, and WHO ICTRP for randomized controlled trials and observational studies (NOS score ≥ 6 or low/moderate ROBINS-I bias risk) published until March 16, 2025. Twelve interventions were evaluated. Primary outcomes: annual change in refractive error (D/year) and axial length (mm/year). Secondary outcomes: adverse events. Random-effects pairwise and network meta-analyses were performed. Inconsistency (node-splitting) and sensitivity analyses (restricting follow-up duration, heterogeneity, and high myopia definition [ ≤ − 6.00D]) assessed robustness. Results Twenty-eight studies (2,885 eyes; 2,202 participants) were included. Repeated Low-level Red Light (RLRL) showed the greatest reduction in axial elongation (–0.43 mm; 95% CI, − 0.51 to − 0.36) and refractive progression (+ 0.95 D; +0.68 to + 1.22) versus control. Rigid gas permeable lenses (RGP: − 0.13 mm [–0.21 to − 0.05]; +0.83 D [+ 0.52 to + 1.14]), orthokeratology (–0.19 mm [–0.26 to − 0.12]; +0.36 D [+ 0.14 to + 0.58]), and posterior scleral reinforcement (PSR: − 0.18 mm [–0.24 to − 0.13]; +0.55 D [+ 0.38 to + 0.73]) were also effective. Multifocal soft contact lenses modestly improved refraction (+ 0.42 D [+ 0.05 to + 0.78]) but not axial length (–0.11 mm [–0.24 to + 0.02]). Atropine 0.01% and DIMS lenses did not significantly affect refraction. RLRL ranked highest (SUCRA: 95.0% axial length; 89.6% refraction). Results were consistent in sensitivity analyses. Adverse events were mild, with no sight-threatening complications. Conclusions RLRL showed the largest estimated effects and ranked highest among the evaluated interventions for one-year control of pediatric high myopia, while PSR, RGP, and orthokeratology also showed potential benefits. These comparative findings should be interpreted cautiously given the predominance of non-randomized evidence, and further head-to-head RCTs are needed to confirm the relative efficacy and long-term safety of these interventions. Key Messages What is known Evidence for myopia-control interventions is well established in children with low-to-moderate myopia, but comparative evidence specifically for pediatric high myopia remains limited. What is new This systematic review and network meta-analysis compares 12 single and combined interventions for pediatric high myopia across 28 studies. Repeated low-level red-light therapy showed the largest estimated effects and ranked highest for both refractive and axial-length control, while posterior scleral reinforcement, rigid gas-permeable lenses, and orthokeratology also showed potential benefits. Evidence for 0.01% atropine and DIMS lenses was limited, and the comparative estimates should be interpreted cautiously because most included studies were non-randomized.
No takes yet. Share an insight, caveat, or question.
Xiao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: